Antimicrobial susceptibility of clinical Campylobacter isolates collected at a German university hospital during the period 2006-2008.
A total of 113 clinical Campylobacter strains (105 C. jejuni, 7 C. coli, 1 C. lari) were collected between 2006 and 2008 and tested for antimicrobial susceptibility to erythromycin, ciprofloxacin, doxycycline and meropenem. Of all the Campylobacter isolates, 52.2% were resistant to ciprofloxacin and 38.0% to doxycycline. None of them was resistant to erythromycin or meropenem. However, 51.3% of all Campylobacter isolates were intermediate susceptible to erythromycin (minimum inhibitory concentration 1-4 mg/l). These data confirm the value of macrolides as the drugs of choice for the treatment of severe Campylobacter infections.
Valenza
Giuseppe
G
Institute of Hygiene and Microbiology, University of Würzburg, Josef-Schneider-Strasse 2/E1, Würzburg, Germany. gvalenza@hygiene.uni-wuerzburg.de
Frosch
Matthias
M
Abele-Horn
Marianne
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002167:Campylobacter / Q000187:drug effects* / Q000302:isolation & purification; D002169:Campylobacter Infections / Q000382:microbiology*; D002648:Child; D002675:Child, Preschool; D024881:Drug Resistance, Bacterial; D005260:Female; D005858:Germany; D006785:Hospitals, University; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D055815:Young Adult
D000900:Anti-Bacterial Agents